Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Epigenomics
|
December 19, 2019
Epigenetic mechanisms driving tumor supportive microenvironment differentiation and function: a role in cancer therapy?
Marvin Sylvestre, Karin Tarte, David Roulois
Biomed Research International
|
March 20, 2013
MUC1-specific cytotoxic T lymphocytes in cancer therapy: induction and challenge
David Roulois, Marc Grégoire, Jean-François Fonteneau
Frontiers in Immunology
|
July 31, 2025
Lymphoid stroma in all its states
Nicolas Barbier, Valentin Isen, Karin Tarte, et al.
Oncoimmunology
|
May 4, 2016
Pharmacological DNA demethylation: Implications for cancer immunotherapy
David Roulois, Helen Loo Yau, Daniel D De Carvalho
European Journal of Immunology
|
December 7, 2011
Downregulation of MUC1 expression and its recognition by CD8⁺ T cells on the surface of malignant pleural mesothelioma cells treated with HDACi
David Roulois, Christophe Blanquart, Clarisse Panterne, et al.
Nucleic Acids Research
|
October 16, 2024
Core enhancers of the 3'RR optimize IgH nuclear position and loop conformation for successful oriented class switch recombination
Charlotte Bruzeau, Ophélie Martin, Justine Pollet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2013
Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells
Jean-Baptiste Guillerme, Nicolas Boisgerault, David Roulois, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 26, 2012
CCL2, galectin-3, and SMRP combination improves the diagnosis of mesothelioma in pleural effusions
Christophe Blanquart, Fabien Gueugnon, Jean-Michel Nguyen, et al.
Cytotherapy
|
February 27, 2022
CD40L-expressing CD4<sup>+</sup> T cells prime adipose-derived stromal cells to produce inflammatory chemokines
Joelle Dulong, Séverine Loisel, Delphine Rossille, et al.
Oncotarget
|
February 25, 2016
Pre-neoplastic epigenetic disruption of transcriptional enhancers in chronic inflammation
Aline C Planello, Rajat Singhania, Ken J Kron, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Epigenomics
|
December 19, 2019
Epigenetic mechanisms driving tumor supportive microenvironment differentiation and function: a role in cancer therapy?
Marvin Sylvestre, Karin Tarte, David Roulois
Biomed Research International
|
March 20, 2013
MUC1-specific cytotoxic T lymphocytes in cancer therapy: induction and challenge
David Roulois, Marc Grégoire, Jean-François Fonteneau
Frontiers in Immunology
|
July 31, 2025
Lymphoid stroma in all its states
Nicolas Barbier, Valentin Isen, Karin Tarte, et al.
Oncoimmunology
|
May 4, 2016
Pharmacological DNA demethylation: Implications for cancer immunotherapy
David Roulois, Helen Loo Yau, Daniel D De Carvalho
European Journal of Immunology
|
December 7, 2011
Downregulation of MUC1 expression and its recognition by CD8⁺ T cells on the surface of malignant pleural mesothelioma cells treated with HDACi
David Roulois, Christophe Blanquart, Clarisse Panterne, et al.
Nucleic Acids Research
|
October 16, 2024
Core enhancers of the 3'RR optimize IgH nuclear position and loop conformation for successful oriented class switch recombination
Charlotte Bruzeau, Ophélie Martin, Justine Pollet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2013
Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells
Jean-Baptiste Guillerme, Nicolas Boisgerault, David Roulois, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 26, 2012
CCL2, galectin-3, and SMRP combination improves the diagnosis of mesothelioma in pleural effusions
Christophe Blanquart, Fabien Gueugnon, Jean-Michel Nguyen, et al.
Cytotherapy
|
February 27, 2022
CD40L-expressing CD4<sup>+</sup> T cells prime adipose-derived stromal cells to produce inflammatory chemokines
Joelle Dulong, Séverine Loisel, Delphine Rossille, et al.
Oncotarget
|
February 25, 2016
Pre-neoplastic epigenetic disruption of transcriptional enhancers in chronic inflammation
Aline C Planello, Rajat Singhania, Ken J Kron, et al.
Page
of 3